Chongqing Lummy Pharmaceutical
Signal active
Investment Firm
Overview
Chongqing LUMMY Pharmaceutical Co., Ltd., headquartered in Chongqing, China, has grown into a high-tech pharmaceutical enterprise integrating R&D, manufacturing,sales and marketing since its establishment in 1999. In October 2009, LUMMY went public on Shenzhen GEM Stock market (Code: 300006). With the total assets of RMB 2.85 billion yuan and registered capital of RMB 812 million yuan, the company has developed an organizational structure comprising several subsidiaries and over 1500 employees.
Highlights
Founded
1999
Industry
Pharmaceutical
Employees
1001-5000
Investment
2
Lead Investment
0
Exits
undefined
Stages
Early Stage Venture, Seed
Investor Type
N/A
Location
Asia
Contact Information
Social
Profile Resume
Chongqing Lummy Pharmaceutical, established in 1999 and headquartered in Asia., specializes in Early Stage Venture, Seed investments across Electronics, Manufacturing, Battery, Financial Services, Venture Capital, Finance, Health Care, Pharmaceutical, Medical, Medical Device. Their recent investments include Sunwoda Electric Vehicle Battery, CCBT Private Equity, Kangdesai Medical Technology, Korea Investment Partners, Beijing Enterprises Medical and Health Industry Group. The highest investment round they participated in was $6.0B. Among their most notable exits are Sunwoda Electric Vehicle Battery and CCBT Private Equity. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Employees
N/A
Investment portfolio
Chongqing Lummy Pharmaceutical has made 2 investments. Their most recent investment was on Jun 25, 2023, when Sunwoda Electric Vehicle Battery raised $229.8M.
investments
2
Diversity investments
0
Lead investments
0
Number of exits
undefined
Investments
2
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| Nov 25, 2021 | Kangdesai Medical Technology | Health Care | 7.8M |
| Jun 25, 2023 | Sunwoda Electric Vehicle Battery | Electronics | 229.8M |
Exits
0
Funding Timeline
Funding rounds
2
Investors
0
Funds
0
Funding Rounds
2
Chongqing Lummy Pharmaceutical has raised 2 rounds. Their latest funding was raised on Jun 25, 2023 from a Series B - Sunwoda Electric Vehicle Battery round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| Nov 25, 2021 | Seed Round - Kangdesai Medical Technology | - | 7.8M | - |
| Jun 25, 2023 | Series B - Sunwoda Electric Vehicle Battery | - | 229.8M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.